Results 201 to 210 of about 32,658 (245)

ChemInform Abstract: Nicotinic Acid Receptor Agonists

ChemInform, 2009
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
P. Douglas Boatman, Jeremy G. Richman, Graeme Semple   +2 more
openaire   +1 more source

Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.

Molecular Pharmacology, 1989
Isoarecolone methiodide (1-methyl-4-acetyl-1,2,3,6-tetrahydropyridine methiodide) was previously shown to be among the most potent agonists tested at the frog neuromuscular junction. Because nicotinic receptors from different sources vary in their selectivities, isoarecolone methiodide as well as 19 additional congeners, most of which were also ...
C E, Spivak, J A, Waters, R S, Aronstam
openaire   +2 more sources

7-Azaindole derivatives as potential partial nicotinic agonists

Bioorganic & Medicinal Chemistry Letters, 2008
We have investigated a series of 7-azaindoles as potential partial agonists of the alpha4beta2 nicotinic acetylcholine receptor (nAChR). Three series of 7-azaindole derivatives have been synthesized and evaluated for rat brain neuronal nicotinic receptor affinity and functional activity.
Axel R, Stoit, Arnold P, den Hartog, Harry, Mons, Sjoerd, van Schaik, Nynke, Barkhuijsen, Cees, Stroomer, Hein K A C, Coolen, Jan Hendrik, Reinders, Tiny J P, Adolfs, Martina, van der Neut, Hiskias, Keizer, Chris G, Kruse   +11 more
openaire   +2 more sources

The therapeutic potential of nicotine and nicotinic agonists for weight control

Expert Opinion on Investigational Drugs, 1999
Transdermal nicotine patches have been successfully introduced as a safe and powerful aid to smoking cessation; this has contributed to the rising interest in additional therapeutic applications for nicotine and synthetic nicotinic agonists. Nicotine and nicotinic agonists may have a therapeutic potential for a variety of disorders, including Alzheimer'
openaire   +2 more sources

Effects of nicotinic agonists on the NMDA receptor

Brain Research, 1991
The cholinergic nicotinic agonists (-)nicotine and lobeline were observed to partially inhibit whole-cell N-methyl-D-aspartate (NMDA)-induced responses in rat cortical neurons in culture. In addition we found that (-)nicotine, (+)nicotine, and lobeline, but not the nicotine metabolite (-)cotinine nor acetylcholine, were able to displace [3H]dizocilpine
E, Aizenman, L H, Tang, I J, Reynolds
openaire   +2 more sources

ABT — 418, a Novel Nicotinic Agonist

1994
With the plethora of receptor targets evolving as the result of nicotinic acetylcholine receptor (nAChR) cloning it is possible that new molecular entities selective for subtypes of nAChRs can be developed which are potentially free of the side effect liabilities associated with (-)-nicotine.
S. P. Arneric, M. Williams, M. W. Holladay, J. T. Wasicak, D. Donnelly-Roberts, D. J. Anderson, P. Pavlik, Y. C. Martin, D. S. Garvey, J. P. Sullivan, G. Wilkie, Susan Wonnacott, S. F. Robinson, James R. Pauly, M. W. Decke, J. D. Brioni, M. J. Buckley, P. Curzon, A. B. O’Neill, D. J. B. Kim, M. Majchrzak, K. Marsh, S. Quigley, A. D. Rodrigues, R. Radek, J. J. Buccafusco, W. J. Jackson, A. V. Terry, K. C. Marsh, M. W. Decker, S. P. Amend, J. R. Pauly   +31 more
openaire   +1 more source

Discriminative stimulus properties of the nicotinic agonist cytisine

Psychopharmacology, 1997
Cytisine binds with high affinity and specificity to neuronal nicotinic receptors but its physiological and behavioural effects are complex and differ from those of nicotine. The present study explores the behavioural aspects further by comparing the discriminative stimulus effects of cystisine with those of nicotine. Two groups of rats were trained to
C J, Chandler, I P, Stolerman
openaire   +2 more sources

Epibatidine, a novel nicotinic receptor agonist

1994
It is speculated that nicotine receptor ligands might be of therapeutic benefit for the treatment of obesity, anxiety, and memory loss. With the exception of nicotine, few selective high-affinity agents exist. (-)Epibatidine (1), isolated from Ecuadoran frogs, shows structural resemblence to (-)nicotine (2). Molecular modeling studies reveal that the N
M. Dukat, D. Dumas, M. I. Damaj, W. Glassco, E. L. May, B. R. Martin, R. A. Glennon, D. M. Wypij, T. Y. Shen, K. R. Creasy, J. Rosecrans, J. P. Sullivan, A. W. Bannon, D. Donnelly-Roberts, D. J. Anderson, M. Piattoni-Kaplan, M. Gopalakrishnan, M. W. Decker, S. P. Arneric, R. Loring, T. McHugh, X. Zhang, J. McKay   +22 more
openaire   +1 more source

Nicotinic Agonists, Antagonists, and Modulators From Natural Sources

Cellular and Molecular Neurobiology, 2005
1. Acetylcholine receptors were initially defined as nicotinic or muscarinic, based on selective activation by two natural products, nicotine and muscarine. Several further nicotinic agonists have been discovered from natural sources, including cytisine, anatoxin, ferruginine, anabaseine, epibatidine, and epiquinamide.
openaire   +2 more sources

Nicotinic Acid Receptor Agonists

Journal of Medicinal Chemistry, 2008
P Douglas, Boatman, Jeremy G, Richman, Graeme, Semple   +2 more
openaire   +2 more sources